OUR BOARD OF DIRECTORS
Trusted industry professionals that help guide the strategic vision of our company
Daniel Spasic, M.Sc
Chairman of the Board
Daniel is a seasoned life science executive with more than 20 years of experience from the industry in clinical and regulatory development. Daniel joined Pharmacia & Upjohn in 1995 and worked in CNS and oncology clinical drug development in Sweden and Italy. He is the founder and owner of TFS International. He grew and managed TFS International’s Clinical Contract Research Operations to a $100 million business in 20 countries and employing 800+ professionals. He sold 60% of his holding in TFS to Ratos AB in 2015.
Patrik Sobocki, M.Sc., Ph.D.
Digital Health Investment Advisor
Patrik is a seasoned life science executive and venture investor with almost 20 years of experience including two start-up journeys in HealthTech and international R&D and commercial leadership roles. Today, Patrik is leading venture investments in HealthTech with Industrifonden. Previously, Patrik was CEO of a HealthTech start-up (Pygargus), which was successfully exited to IMS Health in 2013. He stayed with IMS for 3 years with leadership positions in Europe, Africa and Asia.
David Germonpré, M.Sc., M.B.A.
Health Investment Advisor
David is a seasoned venture capital investor and board member with a strong focus on medtech and digital health. Before joining MTIP, he invested for the Gemma Frisius Fund in spin-offs from Belgium’s KU Leuven. From 2009-2013, Mr. Germonpré advised the Government of Flanders on its investment vehicles. Prior to that, he worked as an investment banker at Dexia Bank. Mr. Germonpré holds a Master’s degree in Commercial Sciences from Ghent University and an Executive MBA at the top-ranked IE Business School (Madrid, Spain).